AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From The Economic Times)
Byline: Writankar Mukherjee
: Ranbaxy Laboratories has withdrawn its AIDS drugs portfolio from South Africa after concerns on quality were raised. This effectively ends Ranbaxy's bid to participate in the multi-million rand AIDS drugs tender of the South African government.
A Ranbaxy spokesperson said, "We have just withdrawn the anti-retroviral (ARV) range of drugs used for the treatment of AIDS, from South Africa."
Ranbaxy recalled the ARVs citing problems with clinical trials it conducted to determine whether the drugs offered the same therapeutic benefits as the originals. The development …